[go: up one dir, main page]

DK1025114T3 - 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet - Google Patents

3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet

Info

Publication number
DK1025114T3
DK1025114T3 DK98946087T DK98946087T DK1025114T3 DK 1025114 T3 DK1025114 T3 DK 1025114T3 DK 98946087 T DK98946087 T DK 98946087T DK 98946087 T DK98946087 T DK 98946087T DK 1025114 T3 DK1025114 T3 DK 1025114T3
Authority
DK
Denmark
Prior art keywords
modified
antibacterial activity
substituted erythromycin
ketolide derivatives
erythromycin ketolide
Prior art date
Application number
DK98946087T
Other languages
Danish (da)
English (en)
Inventor
Yat Sun Or
Zhenkun Ma
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1025114T3 publication Critical patent/DK1025114T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98946087T 1997-09-30 1998-09-16 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet DK1025114T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94087197A 1997-09-30 1997-09-30
US13312198A 1998-08-12 1998-08-12
PCT/US1998/019311 WO1999016779A1 (fr) 1997-09-30 1998-09-16 Derives d'erythromycine cetolidee, modifies en 3'-n et substitues en 6-o, possedant une activite antibacterienne

Publications (1)

Publication Number Publication Date
DK1025114T3 true DK1025114T3 (da) 2004-07-05

Family

ID=26831064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98946087T DK1025114T3 (da) 1997-09-30 1998-09-16 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet

Country Status (22)

Country Link
EP (1) EP1025114B1 (fr)
JP (1) JP2001518476A (fr)
KR (1) KR20010030807A (fr)
CN (1) CN1271363A (fr)
AR (1) AR015727A1 (fr)
AT (1) ATE260293T1 (fr)
AU (1) AU737310B2 (fr)
BG (1) BG104340A (fr)
BR (1) BR9812577A (fr)
CA (1) CA2303930A1 (fr)
CO (1) CO4990958A1 (fr)
DE (1) DE69821964T2 (fr)
DK (1) DK1025114T3 (fr)
ES (1) ES2217579T3 (fr)
HU (1) HUP0004579A3 (fr)
IL (1) IL134608A0 (fr)
NO (1) NO20001439L (fr)
PL (1) PL339575A1 (fr)
PT (1) PT1025114E (fr)
SK (1) SK4562000A3 (fr)
TR (1) TR200000805T2 (fr)
WO (1) WO1999016779A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
US6395710B1 (en) * 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6713615B2 (en) 2000-08-14 2004-03-30 Taisho Pharmaceutical Co., Ltd. Process for producing erythromycin derivative
US20020128213A1 (en) * 2000-09-25 2002-09-12 Leonard Katz Sixteen-membered macrolide compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
WO2006080954A1 (fr) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Derives de cetolides agents antibacteriens
WO2006046112A2 (fr) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Derives de cetolides utiles comme agents antibacteriens
WO2006129257A2 (fr) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Derives de cetolides utilises comme agents antibacteriens
EP1934237A2 (fr) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazoles et procedes de production et d'utilisation de ces composes
EP1928893A2 (fr) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Composes de triazole et preparation et utilisation de ces composes
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
RU2455308C2 (ru) * 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
WO2008099368A1 (fr) * 2007-02-15 2008-08-21 Ranbaxy Laboratories Limited Dérivés de macrolides utilisés comme agents antibactériens
WO2008111020A2 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de macrolide en tant qu'agents antibactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
WO1997017356A1 (fr) * 1995-11-08 1997-05-15 Abbott Laboratories Derives tricycliques d'erythromycine

Also Published As

Publication number Publication date
WO1999016779A1 (fr) 1999-04-08
NO20001439L (no) 2000-05-29
AR015727A1 (es) 2001-05-16
AU9317698A (en) 1999-04-23
CA2303930A1 (fr) 1999-04-08
ATE260293T1 (de) 2004-03-15
KR20010030807A (ko) 2001-04-16
CO4990958A1 (es) 2000-12-26
PT1025114E (pt) 2004-07-30
JP2001518476A (ja) 2001-10-16
DE69821964D1 (de) 2004-04-01
ES2217579T3 (es) 2004-11-01
HUP0004579A2 (hu) 2001-05-28
CN1271363A (zh) 2000-10-25
BR9812577A (pt) 2000-10-17
EP1025114A1 (fr) 2000-08-09
SK4562000A3 (en) 2000-09-12
AU737310B2 (en) 2001-08-16
PL339575A1 (en) 2000-12-18
BG104340A (en) 2001-01-31
NO20001439D0 (no) 2000-03-20
IL134608A0 (en) 2001-04-30
TR200000805T2 (tr) 2000-10-23
EP1025114B1 (fr) 2004-02-25
DE69821964T2 (de) 2004-12-30
HUP0004579A3 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
DK1025114T3 (da) 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet
IS5251A (is) 9-oxím erýþrómýsín afleiður
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
ZA977474B (en) 6-O-substituted ketolides having antibacterial activity.
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
DK1070077T3 (da) 15-Leddede ketolid-lactamer med antibakteriel virkning
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
EP1167375A4 (fr) Derives d'erythromycine
DK0797579T3 (da) Erythromycin A-9-O-oxim-derivater udstyret med antibiotisk aktivitet
EP0766685A4 (fr) Macrolides aryles, alkyles, alcenyles et alcynyles
EP1044985A4 (fr) Derives d'erythromycine
ZA988808B (en) 3'-N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
SI1025114T1 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
HK1031733A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100639B1 (pt) cetolÍdeos 6-o-substituÍdos possuindo atividade antibacteriana.
SI1161438T1 (en) 6-o-substituted macrolides having antibacterial activity
SI1100806T1 (en) Erythromycin derivative with antibiotic activity
HK1037878A (en) 15-membered lactams ketolides with antibacterial activity
ITMI981775A0 (it) Derivato di eritromicina ad attivita' antibiotica